StockrabitBrowse analysts
Analyst questions

Kunal Dhamesh

Firm not listed in source transcripts
DIVISLAB

Divi's Laboratories Limited

All company calls
Divi's Laboratories Limited
1 Aug 2026
Open call
  1. Congratulations on a very good set of numbers. The first one on the significant uptick in the custom synthesis business. I believe that the initial commentary alluded that it still doesn't have a component coming from the dedicated capex project. Is that the correct understanding?

    Read in transcript
  2. Okay. So then just from an understanding perspective, sir, between the -- let's say validation quantity to the capex that we have done. What's the usual ramp-up in terms of the quantities we can see?

    Read in transcript
  3. But sir, anything from history, let's say, can you share that from whatever validation quantity and commercial quantities are generally in this range?

    Read in transcript
+4 more questions in this call